Molecular genetics of the LDL receptor gene in familial hypercholesterolemia

HH Hobbs, MS Brown, JL Goldstein - Human mutation, 1992 - Wiley Online Library
The low density lipoprotein (LDL) receptor is a cell surface transmembrane protein that
mediates the uptake and lysosomal degradation of plasma LDL, thereby providing …

[HTML][HTML] Familial hypercholesterolaemia

AD Marais - The Clinical Biochemist Reviews, 2004 - ncbi.nlm.nih.gov
Familial hypercholesterolaemia (FH), defined as the heritable occurrence of severe
hypercholesterolaemia with cholesterol deposits in tendons and premature heart disease, is …

Lipoprotein (a) in homozygous familial hypercholesterolemia

HG Kraft, A Lingenhel, FJ Raal… - … , and vascular biology, 2000 - Am Heart Assoc
Lipoprotein (a)[Lp (a)] is a quantitative genetic trait that in the general population is largely
controlled by 1 major locus—the locus for the apolipoprotein (a)[apo (a)] gene. Sibpair …

Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa

AJ Tipping, T Pearson, NV Morgan… - Proceedings of the …, 2001 - National Acad Sciences
Fanconi anemia (FA) is a rare, genetically heterogeneous autosomal recessive disorder
associated with progressive aplastic anemia, congenital abnormalities, and cancer. FA has …

The genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations

I De Castro-Orós, M Pocoví, F Civeira - The application of clinical …, 2010 - Taylor & Francis
Familial hypercholesterolemia (FH) is a genetic disorder of lipoprotein metabolism
characterized by high plasma concentrations of low-density lipoprotein cholesterol (LDLc) …

[PDF][PDF] The origins of hypertrophic cardiomyopathy–causing mutations in two South African subpopulations: a unique profile of both independent and founder events

JC Moolman-Smook, WJ De Lange… - The American Journal of …, 1999 - cell.com
Hypertrophic cardiomyopathy (HCM) is an autosomal dominantly inherited disease of the
cardiac sarcomere, caused by numerous mutations in genes encoding protein components …

Familial hypercholesterolemia: epidemiology, Neolithic origins and modern geographic distribution

KE Liyanage, JR Burnett, AJ Hooper… - Critical reviews in …, 2011 - Taylor & Francis
The elucidation of the molecular basis of familial hypercholesterolemia (FH) by Brown and
Goldstein about three decades ago provided the most convincing evidence for a causative …

Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations.

MJ Kotze, WJ De Villiers, K Steyn, JA Kriek… - … and Thrombosis: A …, 1993 - Am Heart Assoc
Two common founder-related gene mutations that affect the low-density lipoprotein receptor
(LDLR) are responsible for approximately 80% of familial hypercholesterolemia (FH) in …

Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia

FJ Raal, AS Pappu, DR Illingworth, GJ Pilcher… - Atherosclerosis, 2000 - Elsevier
Patients with homozygous familial hypercholesterolaemia (HoFH) have markedly elevated
low density lipoprotein (LDL) cholesterol levels that are refractory to standard doses of lipid …

Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR

P Mozas, S Castillo, D Tejedor, G Reyes… - Human …, 2004 - Wiley Online Library
Mutations in the low‐density lipoprotein receptor (LDLR) gene cause familial
hypercholesterolemia (FH), an autosomal dominant inherited disorder associated with an …